Texas 4000 For Cancer
Texas 4000 For Cancer consistently operates with strong financial health and zero reported officer compensation.
EIN: 200371876 · Austin, TX · NTEE: G123 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $856K |
| Total Expenses | $884K |
| Program Spending | 90% |
| CEO/Top Officer Pay | $1 |
| Net Assets | $765K |
| Transparency Score | 95/100 |
Is Texas 4000 For Cancer Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Texas 4000 For Cancer directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Texas 4000 For Cancer
Texas 4000 For Cancer (EIN: 200371876) is a nonprofit organization based in Austin, TX, classified under NTEE code G123. The organization reported total revenue of $856K and total assets of $683K according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Texas 4000 For Cancer's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Texas 4000 For Cancer is a small nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 5.7%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $987K |
| Total Expenses | $884K |
| Surplus / Deficit | +$103K |
| Total Assets | $820K |
| Total Liabilities | $55K |
| Net Assets | $765K |
| Operating Margin | 10.4% |
| Debt-to-Asset Ratio | 6.7% |
| Months of Reserves | 11.1 months |
Financial Health Grade: A
In 2023, Texas 4000 For Cancer reported a surplus of $103K with revenue exceeding expenses, holds 11.1 months of operating reserves (strong position), has a debt-to-asset ratio of 6.7% (very low leverage).
Financial Trends
Over 13 years of filings (2011–2023), Texas 4000 For Cancer's revenue has grown at a compound annual growth rate (CAGR) of 5.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +6.6% | -2.2% | +22.8% |
| 2022 | -8.0% | -27.9% | -14.2% |
| 2021 | +10.6% | +47.8% | -17.6% |
| 2020 | -31.5% | -14.4% | +10.0% |
| 2019 | +4.1% | -7.7% | +3.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Texas 4000 For Cancer with a Mission Score of 95 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Texas 4000 For Cancer allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $103K, with revenue exceeding expenses.
- Debt-to-asset ratio: 6.7%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that the organization's leadership either volunteers their time or is compensated through non-officer roles, which is highly unusual for an organization with nearly $1 million in annual revenue and suggests a strong commitment to directing funds to the mission.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Texas 4000 For Cancer's IRS 990 filings:
- Significant revenue fluctuations year-over-year (e.g., $1.3M in 201909 to $910K in 202009), which could indicate reliance on variable funding sources.
Strengths
The following positive indicators were identified for Texas 4000 For Cancer:
- Consistent reporting of 0% officer compensation, indicating extremely low administrative overhead related to executive salaries.
- Healthy asset-to-liability ratio, with assets of $819,632 significantly exceeding liabilities of $54,853 in 202309, demonstrating strong financial stability.
- Generally positive net asset growth over the past decade, indicating sound financial management and reserve building.
- Consistent filing of IRS 990 forms over 13 periods, demonstrating strong transparency and compliance.
Frequently Asked Questions about Texas 4000 For Cancer
Is Texas 4000 For Cancer a legitimate charity?
Texas 4000 For Cancer (EIN: 200371876) is a registered tax-exempt nonprofit based in Texas. Our AI analysis gives it a Mission Score of 95/100. It has 13 years of IRS 990 filings on record. Total revenue: $856K. 1 red flag identified. 4 strengths noted. Financial health grade: A.
How does Texas 4000 For Cancer spend its money?
Texas 4000 For Cancer directs 90% of its spending to programs and services. Fundraising costs 3%. This exceeds the 65% industry benchmark.
Are donations to Texas 4000 For Cancer tax-deductible?
Texas 4000 For Cancer is registered as a tax-exempt nonprofit (EIN: 200371876). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
How much does the Texas 4000 For Cancer CEO make?
Texas 4000 For Cancer's highest-compensated officer earns $1 annually. The organization reported $856K in total revenue. Executive compensation data is disclosed in IRS 990 filings.
What percentage of Texas 4000 For Cancer's spending goes to programs?
Texas 4000 For Cancer directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Texas 4000 For Cancer compare to similar nonprofits?
With a transparency score of 95/100 (Excellent), Texas 4000 For Cancer is above average for NTEE category G123 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Texas 4000 For Cancer located?
Texas 4000 For Cancer is headquartered in Austin, Texas and files with the IRS under EIN 200371876. It is classified under NTEE code G123.
How many years of IRS 990 filings does Texas 4000 For Cancer have?
Texas 4000 For Cancer has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $856K in total revenue.
How does Texas 4000 For Cancer manage to operate with 0% officer compensation?
The filings consistently show 0% officer compensation, which could mean that the organization's leadership is entirely volunteer-based, or that compensation is structured in a way that it is not reported under 'officer compensation' on the 990 form. This practice significantly reduces administrative overhead.
Is the organization's revenue stable?
Revenue has fluctuated over the years, ranging from a low of $841,001 in 201409 to a high of $1,329,475 in 201909. While there are variations, it has consistently remained near or above $900,000 in recent years, indicating a generally stable funding base.
What is the trend in the organization's net assets?
Net assets have shown a positive trend, increasing from $671,659 in 201409 to $819,632 in 202309, with some fluctuations. This indicates that the organization is generally building its financial reserves.
Filing History
IRS 990 filing history for Texas 4000 For Cancer showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), Texas 4000 For Cancer's revenue has grown by 94.2%, moving from $508K to $987K. Total assets increased by 16% over the same period, from $707K to $820K. Total functional expenses rose by 73.8%, from $509K to $884K. In its most recent filing year (2023), Texas 4000 For Cancer reported a surplus of $103K, with revenue exceeding expenses. The organization holds $55K in liabilities against $820K in assets (debt-to-asset ratio: 6.7%), resulting in net assets of $765K.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $987K | $884K | $820K | $55K | — | — |
| 2022 | $926K | $904K | $668K | $20K | — | — |
| 2021 | $1.0M | $1.3M | $778K | $105K | — | View 990 |
| 2020 | $910K | $849K | $944K | $66K | — | View 990 |
| 2019 | $1.3M | $992K | $859K | $47K | — | View 990 |
| 2018 | $1.3M | $1.1M | $832K | $360K | — | View 990 |
| 2017 | $1.1M | $1.2M | $743K | $473K | — | View 990 |
| 2016 | $975K | $901K | $643K | $339K | — | View 990 |
| 2015 | $860K | $924K | $692K | $462K | — | View 990 |
| 2014 | $841K | $795K | $672K | $377K | — | View 990 |
| 2013 | $777K | $699K | $608K | $359K | — | View 990 |
| 2012 | $558K | $520K | $463K | $292K | — | View 990 |
| 2011 | $508K | $509K | $707K | $578K | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $987K, expenses of $884K, and assets of $820K (revenue +6.6% year-over-year).
- 2022: Revenue of $926K, expenses of $904K, and assets of $668K (revenue -8.0% year-over-year).
- 2021: Revenue of $1.0M, expenses of $1.3M, and assets of $778K (revenue +10.6% year-over-year).
- 2020: Revenue of $910K, expenses of $849K, and assets of $944K (revenue -31.5% year-over-year).
- 2019: Revenue of $1.3M, expenses of $992K, and assets of $859K (revenue +4.1% year-over-year).
- 2018: Revenue of $1.3M, expenses of $1.1M, and assets of $832K (revenue +12.6% year-over-year).
- 2017: Revenue of $1.1M, expenses of $1.2M, and assets of $743K (revenue +16.4% year-over-year).
- 2016: Revenue of $975K, expenses of $901K, and assets of $643K (revenue +13.4% year-over-year).
- 2015: Revenue of $860K, expenses of $924K, and assets of $692K (revenue +2.2% year-over-year).
- 2014: Revenue of $841K, expenses of $795K, and assets of $672K (revenue +8.2% year-over-year).
- 2013: Revenue of $777K, expenses of $699K, and assets of $608K (revenue +39.1% year-over-year).
- 2012: Revenue of $558K, expenses of $520K, and assets of $463K (revenue +9.9% year-over-year).
- 2011: Revenue of $508K, expenses of $509K, and assets of $707K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Texas 4000 For Cancer:
Data Sources and Methodology
This transparency report for Texas 4000 For Cancer is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.